Loading...
NPI 1366428120 · Providence, RI · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Richard Bryan is a ophthalmology physician provider located in Providence, Rhode Island. This profile covers 13 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Richard Bryan |
| Address | 120 Dudley St |
| City | Providence |
| State | RI |
| ZIP | 02905 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | December 22, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $883K |
| Medicaid | $70.1K |
This provider operates as a retina-focused ophthalmology practice: the Medicare revenue mix is dominated by intravitreal biologic drug administrations (J0178, J2777, J0179) and procedure 67028 for intravitreal injection, supported by retinal imaging (92134) and standard E/M visits (99213/99214). The presence of high-revenue anti-VEGF and newer anti–VEGF-similar agents indicates the practice’s workflow centers on recurring in-office injections and retinal disease management rather than primarily surgical or general ophthalmology care.
Medicare revenue is heavily concentrated in a few drug-administration codes: the precomputed top three Medicare codes (J0178, J2777, J0179) account for 79.1% of the provider’s total Medicare revenue, with J0178 alone representing $454.3K (51.5% of Medicare revenue). This concentration signals dependency on a small number of high-cost injectable therapies for Medicare income.
On the Medicaid side the top three codes account for the entirety of Medicaid revenue (100.0%), and Medicaid billing is concentrated in treatment and imaging: 67028 contributes $40.7K (57.8% of Medicaid revenue) and 92134 contributes $22.1K (31.4% of Medicaid revenue). The Medicaid mix mirrors the Medicare profile in clinical focus—intravitreal procedures and retinal imaging dominate reimbursed services.
The provider’s payer mix is skewed toward Medicare by scale: lifetime Medicare revenue is $883K versus $70.1K from Medicaid, so Medicare is the clear primary revenue source. Medicaid activity exists but is a much smaller share of total public-payer revenue, indicating the practice serves substantially more Medicare patients or bills materially more to Medicare for higher-cost injectable agents.
Competitive standing on key codes is modest to typical rather than dominant: J0178 ranks #1668 of 3204 (48th percentile; typical, unremarkable volume), J2777 ranks #1435 of 2039 (29th percentile; typical, unremarkable volume), and J0179 ranks #42 of 64 (35th percentile; typical, unremarkable volume). Even the high-revenue imaging code 92134 is described as typical, unremarkable volume in its ranking, so the practice appears to be a steady regional participant rather than an outlier leader for these services nationally or in-state.
Procedure-level Medicaid rankings indicate middle-tier in-state participation: 67028 ranks #7 of 14 (54th percentile; typical, unremarkable volume) and 92134 ranks #7 of 24 (74th percentile; typical, unremarkable volume). Those placements suggest the provider is competitive within Rhode Island for injection and retinal imaging services but not a clear statewide leader.
The provider has an established billing history with long tenure: NPI enumerated 2005-12-22 (~21 years ago), which supports the interpretation of a stable, long-running ophthalmology practice that has built recurring injection-based service lines over time. This longevity combined with the revenue concentration in injectable therapies suggests an operational focus on chronic retinal disease management and repeated in-office procedures.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 670 | $680 | $454.3K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 5,700 | $30 | $159.6K |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 340 | $250 | $83.3K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 680 | $100 | $65K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,190 | $30 | $38K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 210 | $100 | $20.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 290 | $70 | $19.1K |
| J9035 | Injection, bevacizumab, 10 mg | 280 | $60 | $15.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 140 | $100 | $13.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 60 | $120 | $7.3K |
Showing 1–10 of 13
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
13 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 8 | 10 | 670 | $690 | $601.6K |
| J2777 | 4 | 10 | 5,790 | $30 | $158K |
| J0179 | 1 | 10 | 340 | $250 | $83.4K |
| 67028 | 7 | 20 | 610 | $90 | $58.9K |
| 92014 | 56 | 190 | 120 | $80 | $16.3K |
| 99214 | 710 | 1,950 | 100 | $80 | $11.7K |
| J9035 | 3 | 20 | 160 | $50 | $9.5K |
| 99213 | 224 | 1,950 | 70 | $60 | $7.4K |
| 92134 | 9 | 120 | 50 | $30 | $6.6K |
| 99204 | 122 | 740 | 30 | $110 | $4.6K |
Showing 1–10 of 13
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 190 | $210 | $40.7K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,000 | $20 | $22.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 160 | $50 | $7.6K |
How this provider's Medicaid billing volume and revenue compare to other Rhode Island providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Rhode Island median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 7 | 10 | 170 | $230 | $144.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,250 | 2,050 | 300 | $50 | $72.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 7 | 20 | 560 | $50 | $61.6K |
Other providers in the same ZIP code as Richard Bryan, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.